$14.66
-0.83 (-5.36%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where BWAY is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
20 interventional · 1 observational
Held by 5 tracked-famous managers (RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC, Man Group plc, SUSQUEHANNA INTERNATIONAL GROUP, LLP) · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)NCT07216872Difference in proportion of patients who attain zero (0) heavy drinking daysRandomized · Triple-masked · Treatment | Not applicable | Recruiting | Device: Deep TMS (DTMS), Sham (No Treatment) | Alcohol Use Disorder, Alcoholism, Alcohol Abuse, Alcohol Dependence, Alcohol Abuse/Dependence, Alcohol Addiction | 186 | 2027-11-01 | in 439 d | 2026-07-17 |
| New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)NCT06357832Change in Hamilton Depression Rating Scale (HDRS)-21 score in the investigational groupRandomized · Double-masked · Treatment | Not applicable | Completed | Device: Brainsway Deep TMS System | Major Depressive Disorder | 104 | 2025-02-26actual | — | 2026-03-10 |
| Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD SubjectsNCT05404360Yale Brown Obsessive Compulsive Scale (YBOCS)Randomized · Triple-masked · Treatment | Not applicable | Unknown status | Device: BrainsWay Deep TMS HAC/H7-Coil, BrainsWay Deep TMS Sham Coil | Obsessive-Compulsive Disorder | 124 | Jun 2024 | — | 2022-07-20 |
| Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar DepressionNCT01566591HDRS-21 Score measured by change from baseline.Randomized · Triple-masked · Treatment | Not applicable | Unknown status | Device: Deep TMS Treatment, Sham Treatment | Bipolar Depression | 120 | Dec 2021 | — | 2021-02-04 |
| Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)NCT04455646observationalPatient Patient Health Questionnaire (PHQ) Patient Health Questionnaire (PHQ) Patient Health Questionnaire (PHQ) Health Questionnaire (PHQ) | — | Unknown status | Behavioral: CBT-based, mobile-delivered, intervention platform | Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment | 540 | 2021-08-26 | — | 2020-07-09 |
| Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive ImpairmentNCT01464515MindstreamsRandomized · Quadruple-masked · Other | Phase 1 | Unknown status | Device: H-Coil Deep TMS, SHAM Coil TMS | Mild Cognitive Impairment | 30 | Jan 2021 | — | 2020-07-14 |
| Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)NCT03012724HDRS-21 Score Change From BaselineRandomized · Triple-masked · Treatment | Not applicable | Unknown status | Device: H7-Coil, H1-Coil | Major Depressive Disorder (MDD) | 106 | Dec 2020 | — | 2020-07-15 |
| Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) SubjectsNCT01343732Y-BOCS Scale (Yale-Brown Obsessive Compulsive Disorder)Randomized · Open-label · Other | Not applicable | Unknown status | Device: Deep TMS | Obsessive Compulsive Disorder | 40 | Nov 2020 | — | 2020-07-14 |
| Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in AdultsNCT01196910Conners' Adult ADHD Rating ScaleRandomized · Double-masked · Treatment | Phase 1 | Unknown status | Device: treatment by HLPFC coil | Attention Deficit Hyperactivity Disorder | 45 | Sep 2020 | — | 2020-07-14 |
| Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as UsualNCT02260765HDRS-21Randomized · Open-label · Other | Not applicable | Withdrawnsponsor's stated reason: This study was never funded therefore no patients were enrolled. | Device: dTMS | Depression | 0 | Sep 2020 | — | 2021-02-08 |
| Brainsway DTMS for Treatment of MDD Using iTBSNCT04679753The primary outcome measure was the change from baseline in HDRS-21 scores at the 5 week visit.Non-randomized · Open-label · Treatment | Phase 4 | Completed | Device: Brainsway DTMS with intermittent Theta Burst Stimulation (iTBS), Brainsway DTMS with High Frequency (HF) Stimulation | Major Depressive Disorder | 177 | 2020-07-01actual | — | 2020-12-23 |
| A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)NCT02479906CAPS-5 ScoreRandomized · Triple-masked · Treatment | Not applicable | Terminatedsponsor's stated reason: The results did not demonstrate sufficient clinical benefit induced specifically by the active treatment to justify continuation of the trial. | Device: Deep TMS System, Sham Treatment | Post-Traumatic Stress Disorder | 203 | 2020-02-06actual | — | 2020-05-14 |
| Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.NCT02126124Continuous Quit RateRandomized · Single-masked · Treatment | Phase 3 | Completed | Device: Sham Treatment, Active dTMS Treatment | Smoking Cessation | 224 | 2019-11-14actual | — | 2020-12-04 |
| An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCDNCT02229903Yale Brown Obsessive Compulsive Scale (YBOCS) scoreRandomized · Quadruple-masked · Treatment | Not applicable | Completed | Device: Active DTMS Treatment, Sham Treatment | Obsessive Compulsive Disorder | 100 | Jun 2017actual | — | 2020-07-15 |
| Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.NCT01388179CGI-I(clinical global impression-I) as a measure for social functioningRandomized · Double-masked · Treatment | Phase 2 | Terminatedsponsor's stated reason: Sponsor decision to stop the study | Device: Transcranial Magnetic Stimulation | Autism | 20 | 2016-12-31actual | — | 2018-04-17 |
| Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus.NCT02053961TQ - Tinnitus questionnaireRandomized · Double-masked · Treatment | Phase 2 | Withdrawn | Device: Deep Transcranial Magnetic Stimulation, Deep Transcranial Magnetic Stimulation | Tinnitus | 0 | Jan 2016 | — | 2018-01-25 |
| The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph DiseaseNCT02039206Scale for the Assessment and Rating of Ataxia (SARA)Open-label · Treatment | Phase 2 | Completed | Device: Deep TMS | Machado Joseph Disease (SCA3) | 20 | Feb 2015actual | — | 2018-01-25 |
| Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's DiseaseNCT01179373cognitive functioning score by ADAS-COGRandomized · Double-masked · Treatment | Phase 2 | Completed | Device: TMS, H coil | Alzheimer's Disease | 45 | Jan 2015actual | — | 2018-01-25 |
| Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal LobeNCT01599208Change in memory based on the timeframe of the online stimulationRandomized · Single-masked · Basic science | Early Phase 1 | Withdrawnsponsor's stated reason: no IRB | Device: TMS | Effect of Deep Transcranial Magnetic Stimulation on Memory | 0 | Jan 2015 | — | 2018-01-25 |
| Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)NCT01361815The tolerability and safety of H-coil deep rTMS treatment in combination with SSRI medicationsOpen-label · Treatment | Not applicable | Completed | Device: H-Coil Deep TMS in combination with SSRIs | Major Depressive Disorder, Recurrent, Unspecified, Major Depressive Disorder, Single Episode, Unspecified | 75 | Dec 2014actual | — | 2020-07-15 |
| Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression DisorderNCT00927173HDRS-21Randomized · Quadruple-masked · Treatment | Not applicable | Completed | Device: Brainsway H-Coil Deep TMS System, Brainsway H-Coil Deep TMS System (Sham treatment) | Major Depressive Disorder | 233 | Mar 2012actual | — | 2020-07-15 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19